Previous Close | 7.53 |
Open | 7.60 |
Bid | 7.54 x 200 |
Ask | 7.58 x 200 |
Day's Range | 7.39 - 7.71 |
52 Week Range | 3.67 - 13.50 |
Volume | |
Avg. Volume | 2,129,070 |
Market Cap | 723.793M |
Beta (5Y Monthly) | -0.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Bezuclastinib Trials Progress as Cogent Biosciences Inc. Strengthens Cash Position
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Key Insights Given the large stake in the stock by institutions, Cogent Biosciences' stock price might be vulnerable to...